Revolution Medicines Seeks $100 Million IPO

EnterpriseWorks graduate Revolution Medicines filed for an initial public offering of $100 million on January 17, 2020. ... Read More

Posted on: January 21, 2020

EnterpriseWorks Graduate SNOOZ Raises $1.35 Million

SNOOZ, an EnterpriseWorks graduate, raised $1.35 million in a seed round led by Serra Ventures. Founded in 2015 by Ma... Read More

Posted on: October 31, 2019

PhotoniCare, Inc. Receives Phase I SBIR Award from NIH

PhotoniCare, a startup located in EnterpriseWorks in the University of Illinois Research Park, announced through press r... Read More

Posted on: August 7, 2019

Revolution Medicines, EnterpriseWorks Graduate, Secures $100 Million to Target RAS Pathway

Revolution Medicines has secured $100 million in Series C financing that will be used to support the development of the ... Read More

Posted on: July 10, 2019

ATSP Innovations Selected for Phase I SBIR by NASA

Jacob Meyer, University of Illinois alumnus and co-founder of ATSP Innovations, announced on June 18 that ATSP Innovatio... Read More

Posted on: June 19, 2019

Reconstruct Receives $7.7 Million Series A Investment Led By Cultivation Capital

Reconstruct, a Research Park startup, has closed a $7.7 million series A round led by Cultivation Capital. Investors als... Read More

Posted on: May 14, 2019

Research Park Development Partner Atkins Provides Gift for Baseball Training Center

The University of Illinois Division of Intercollegiate Athletics will break ground on a state-of-the-art indoor practice... Read More

Posted on: November 15, 2018

DPI Funding to Support Research Park Growth

Part of the state funding allocated to the University of Illinois for the Discovery Partners Institute and its statewide... Read More

Posted on: August 30, 2018

Photonicare awarded $2.1 million SBIR funding for patient trials

A Research Park startup is making great strides in providing healthcare providers with better diagnostic tools. The Nati... Read More

Posted on: July 30, 2018

Revolution Medicines Makes $50mil Deal

EnterpriseWorks incubator graduate, Revolution Medicines, sold the sharing rights to one of their leading drug candidate... Read More

Posted on: July 24, 2018